(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CELL-CHEX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CELL-CHEX

ST13

US500000085410938

Class

5

Filing

85410938

Registration

4166939

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

03/01/2023

Trademark type

Word

Nice classes

5

Filing date

08/30/2011

Registration date

07/03/2012

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/24/2023

Last transaction

01/24/2023

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

03/03/2000

First use in commerce

04/01/2000

Drawing code

4

Owner type

16

Owner location

LA VISTA, NE, US

Examiner

BROWN, TINA

Law office

L50

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

STRECK LLC
Streck, Inc.

Representatives

Gregory J. Chinlund MARSHALL, GERSTEIN & BORUN LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Diagnostic reagents for use as a procedural control for use in monitoring total cell counts and white cell differentiation in body fluidsspinal fluidsynovial fluidperitoneal fluidpericardial fluidpleural fluid

Publications

History of USPTO decisions and trademark events.

35 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

03/01/2023

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

01/24/2023

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

01/24/2023

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

01/24/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/20/2023

E89R

TEAS SECTION 8 & 9 RECEIVED

07/05/2022

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

07/03/2021

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

09/02/2017

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

09/02/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/02/2017

E815

TEAS SECTION 8 & 15 RECEIVED

07/26/2017

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

07/03/2017

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/21/2015

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/21/2015

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/17/2013

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/21/2013

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/06/2012

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/06/2012

R.PR

REGISTERED-PRINCIPAL REGISTER

07/03/2012

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/17/2012

PUBO

PUBLISHED FOR OPPOSITION

04/17/2012

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/28/2012

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/09/2012

ALIE

ASSIGNED TO LIE

03/09/2012

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/22/2012

XAEC

EXAMINER'S AMENDMENT ENTERED

02/22/2012

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

02/22/2012

GNEA

EXAMINERS AMENDMENT E-MAILED

02/22/2012

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/22/2012

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/21/2011

GNRT

NON-FINAL ACTION E-MAILED

12/21/2011

CNRT

NON-FINAL ACTION WRITTEN

12/21/2011

DOCK

ASSIGNED TO EXAMINER

12/16/2011

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/06/2011

NWAP

NEW APPLICATION ENTERED

09/02/2011

Continuous trademark protection

Get notified about every new filing that threatens CELL-CHEX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.